GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock - Currency: USD
Taking everything into account, GDRX scores 6 out of 10 in our fundamental rating. GDRX was compared to 36 industry peers in the Health Care Technology industry. GDRX has an average financial health and profitability rating. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes GDRX very considerable for value investing!
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
In the past year GDRX had a positive cash flow from operations.
GDRX had negative earnings in 4 of the past 5 years.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 2.19%, GDRX belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
The Return On Equity of GDRX (4.34%) is better than 91.67% of its industry peers.
GDRX has a Return On Invested Capital of 5.42%. This is amongst the best in the industry. GDRX outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.19% | ||
| ROE | 4.34% | ||
| ROIC | 5.42% |
ROA(3y)-0.48%
ROA(5y)-4.6%
ROE(3y)-0.99%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of GDRX (3.56%) is better than 91.67% of its industry peers.
GDRX's Profit Margin has declined in the last couple of years.
GDRX's Operating Margin of 10.25% is amongst the best of the industry. GDRX outperforms 91.67% of its industry peers.
In the last couple of years the Operating Margin of GDRX has declined.
The Gross Margin of GDRX (93.84%) is better than 100.00% of its industry peers.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.25% | ||
| PM (TTM) | 3.56% | ||
| GM | 93.84% |
OM growth 3Y66.5%
OM growth 5Y-25.43%
PM growth 3YN/A
PM growth 5Y-34.7%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GDRX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for GDRX remains at a similar level compared to 5 years ago.
GDRX has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.25, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.25, GDRX perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
GDRX has a debt to FCF ratio of 6.18. This is a slightly negative value and a sign of low solvency as GDRX would need 6.18 years to pay back of all of its debts.
The Debt to FCF ratio of GDRX (6.18) is better than 61.11% of its industry peers.
GDRX has a Debt/Equity ratio of 0.74. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
GDRX has a worse Debt to Equity ratio (0.74) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.18 | ||
| Altman-Z | 1.25 |
ROIC/WACC0.49
WACC11.07%
2.3 Liquidity
GDRX has a Current Ratio of 5.24. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.24, GDRX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
GDRX has a Quick Ratio of 5.24. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
GDRX has a Quick ratio of 5.24. This is amongst the best in the industry. GDRX outperforms 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.24 | ||
| Quick Ratio | 5.24 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.24%, which is quite good.
GDRX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -25.13% yearly.
Looking at the last year, GDRX shows a small growth in Revenue. The Revenue has grown by 4.34% in the last year.
GDRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.34% yearly.
EPS 1Y (TTM)17.24%
EPS 3Y0%
EPS 5Y-25.13%
EPS Q2Q%12.5%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%2.57%
3.2 Future
GDRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.44% yearly.
Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 5.92% on average per year.
EPS Next Y19.87%
EPS Next 2Y19.07%
EPS Next 3Y16.92%
EPS Next 5Y20.44%
Revenue Next Year3.3%
Revenue Next 2Y4.32%
Revenue Next 3Y5.19%
Revenue Next 5Y5.92%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.28, which indicates a correct valuation of GDRX.
97.22% of the companies in the same industry are more expensive than GDRX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.54, GDRX is valued a bit cheaper.
A Price/Forward Earnings ratio of 10.38 indicates a reasonable valuation of GDRX.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaper than 97.22% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.44. GDRX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.28 | ||
| Fwd PE | 10.38 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
88.89% of the companies in the same industry are more expensive than GDRX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.84 | ||
| EV/EBITDA | 11.88 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GDRX may justify a higher PE ratio.
A more expensive valuation may be justified as GDRX's earnings are expected to grow with 16.92% in the coming years.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y19.07%
EPS Next 3Y16.92%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:GDRX (7/21/2025, 10:26:49 AM)
4.855
+0.18 (+3.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners59.39%
Inst Owner Change-0.02%
Ins Owners11.68%
Ins Owner Change4.6%
Market Cap1.73B
Analysts75.65
Price Target6.44 (32.65%)
Short Float %6.29%
Short Ratio3.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.88%
Min EPS beat(2)-8.64%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.74%
Min EPS beat(4)-10.15%
Max EPS beat(4)-7.12%
EPS beat(8)4
Avg EPS beat(8)0.12%
EPS beat(12)8
Avg EPS beat(12)16.11%
EPS beat(16)10
Avg EPS beat(16)12.75%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.2%
Revenue beat(12)2
Avg Revenue beat(12)-1.38%
Revenue beat(16)2
Avg Revenue beat(16)-1.48%
PT rev (1m)-0.52%
PT rev (3m)-6.42%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)-1.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.67%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.28 | ||
| Fwd PE | 10.38 | ||
| P/S | 2.17 | ||
| P/FCF | 21.84 | ||
| P/OCF | 11.53 | ||
| P/B | 2.65 | ||
| P/tB | 52.55 | ||
| EV/EBITDA | 11.88 |
EPS(TTM)0.34
EY7%
EPS(NY)0.47
Fwd EY9.64%
FCF(TTM)0.22
FCFY4.58%
OCF(TTM)0.42
OCFY8.67%
SpS2.23
BVpS1.83
TBVpS0.09
PEG (NY)0.72
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.19% | ||
| ROE | 4.34% | ||
| ROCE | 6.86% | ||
| ROIC | 5.42% | ||
| ROICexc | 7.25% | ||
| ROICexgc | 23.91% | ||
| OM | 10.25% | ||
| PM (TTM) | 3.56% | ||
| GM | 93.84% | ||
| FCFM | 9.96% |
ROA(3y)-0.48%
ROA(5y)-4.6%
ROE(3y)-0.99%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.98%
ROICexcg growth 5Y-33.13%
ROICexc growth 3Y52.13%
ROICexc growth 5Y-28.35%
OM growth 3Y66.5%
OM growth 5Y-25.43%
PM growth 3YN/A
PM growth 5Y-34.7%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.18 | ||
| Debt/EBITDA | 3.1 | ||
| Cap/Depr | 94.67% | ||
| Cap/Sales | 8.9% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 95.96% | ||
| Profit Quality | 279.61% | ||
| Current Ratio | 5.24 | ||
| Quick Ratio | 5.24 | ||
| Altman-Z | 1.25 |
F-Score8
WACC11.07%
ROIC/WACC0.49
Cap/Depr(3y)84.57%
Cap/Depr(5y)109.65%
Cap/Sales(3y)7.83%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.24%
EPS 3Y0%
EPS 5Y-25.13%
EPS Q2Q%12.5%
EPS Next Y19.87%
EPS Next 2Y19.07%
EPS Next 3Y16.92%
EPS Next 5Y20.44%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%2.57%
Revenue Next Year3.3%
Revenue Next 2Y4.32%
Revenue Next 3Y5.19%
Revenue Next 5Y5.92%
EBIT growth 1Y367.7%
EBIT growth 3Y69.92%
EBIT growth 5Y-13.99%
EBIT Next Year38.86%
EBIT Next 3Y17.8%
EBIT Next 5Y14.15%
FCF growth 1Y-13.59%
FCF growth 3Y-7.56%
FCF growth 5Y8%
OCF growth 1Y0.95%
OCF growth 3Y0.96%
OCF growth 5Y17.17%